No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
AstraZeneca Acquires Gracell Biotechnologies for $1.2B
AstraZeneca announced the successful acquisition of Gracell Biotechnologies, a global clinical-stage biopharmaceutical company specialising in cell therapies for cancer and autoimmune diseases. Gracell's portfolio notably includes GC012F a clinical stage chimeric...